共查询到20条相似文献,搜索用时 62 毫秒
1.
为了研究原始热带雨林鹦歌岭土壤放线菌(Streptomyces sp.)YG-7的次生代谢产物及其α-葡萄糖苷酶抑制活性,采用多种柱色谱方法对土壤放线菌YG-7的发酵产物进行分离纯化得到9个化合物,经过波谱数据分析分别鉴定为:(1) 2-acetamido-5-chlorobenzamide, (2) cyclo (L-Pro-L-Leu), (3) 3,6-dibenzylidene-2,5-piperazinedione, (4) albonoursin, (5) (3Z,6S)-3-benzylidene-6-isobutylpiperazine-2,5-dione, (6) 3-hydroxy-2-methyl-4-pyrone, (7) isophthalic acid, (8) methyl 3-carbamoylbenzoate, (9) 2,3-dihydroxypropyl hexadecanoate. 其中,化合物1、7和8为新天然产物。活性测试结果表明化合物1、3~5和7~8对α-葡萄糖苷酶具有明显的抑制活性。 相似文献
2.
为了研究红树林来源真菌Xylaria sp. HNWSW-2的次生代谢产物及其生物活性,综合利用多种色谱技术对该菌株发酵产物进行分离纯化,结合波谱学与理化常数分析进行化合物结构鉴定,分别采用液体浸泡法和Ellman比色法对化合物的全齿复活线虫致死活性和乙酰胆碱酯酶抑制活性进行测试。从Xylaria sp. HNWSW-2发酵产物乙酸乙酯萃取物中分离鉴定了7个异香豆素类化合物,分别为 (S)-(+)-8-O-methylmellein (1),(3S,4S)-(+)-4-hydroxy-8-O- methylmellein (2),(3S,4R)-(+)-4-hydroxy-8-O-methylmellein (3),(3S,4S)-(+)-4-hydroxymellein (4),(3S,4R)-(+)-4- hydroxymellein (5),(3R,4R)-(-)-4-hydroxy-5-methylmellein (6)和(3R,4S)-(+)-4-hydroxy-5-methylmellein (7)。其中,化合物1具有较强全齿复活线虫致死活性,化合物1~3、6和7具有一定的乙酰胆碱酯酶抑制活性。本研究首次发现化合物(S)-(+)-8-O-methylmellein具有较强的抗线虫活性,为相关杀线虫药物的研发提供理论依据。 相似文献
3.
放线菌次生代谢产物对不同来源大豆胞囊线虫J2毒性的研究 总被引:1,自引:1,他引:1
抗生素是控制植物病害的重要手段之一,而放线菌是抗生素的主要产生菌。针对已筛选到的5株放线菌C25-3、H-4、H-2、C44和C49,利用室内培养法对其发酵液抑制田间大豆胞囊线虫J2混合群体的活性作用进行了比较研究。结果表明:发酵液4×稀释浓度下,处理24h后,C25-3对大豆胞囊线虫J2的毒性最高,其校正死亡率达到95%左右;其他4株菌的次生代谢产物也具有一定的毒杀作用,对J2的校正死亡率均达到60%以上。5株放线菌菌株中,C25-3,H-2和C44对大豆胞囊线虫J2的毒性不因线虫的致病性和活性差异而改变,而C49和H-4表现出因线虫的致病性和活性差异而改变的特性。 相似文献
4.
对紫海胆共生真菌Aspergillus sp.HDf2的次生代谢产物进行分离和鉴定。采用摇瓶液体发酵,运用柱层析等方法对其发酵液成分进行分离纯化,经波谱解析和质谱分析进行结构鉴定,并运用滤纸片法对化合物进行体外抗金黄色葡萄球菌的活性测试。结果从该真菌发酵产物中鉴定出2个secospiculisporic acid新类似物,分别为secospiculisporic acid B(1)和secospiculisporic acid C(2),其中化合物1具有弱抗菌活性,抑菌直径为9.2 mm(20 mg/mL)。首次对化合物1的NMR数据进行了归属,化合物2为secospiculisporic acid类的新化合物。 相似文献
5.
采用常规色谱分离技术对分离自健康紫海胆肠道的稀有放线菌Micromonospora sp. HDa2发酵液的化学成分进行分离纯化,并以波谱技术确定化合物的结构。结果表明:从放线菌Micromonospora sp. HDa2的发酵液乙酸乙酯提取物中分离鉴定了6个已知结构的环二肽化合物,分别为环(苯丙-缬)二肽(1)、环(苯丙-亮)二肽(2)、环(苯丙-异亮)二肽(3)、环(苯丙-苯丙)二肽(4)、环(亮-亮)二肽(5)和环(亮-异亮)二肽(6)。对紫海胆肠道放线菌进行分离,结果发现以上化合物均是从Micromonospora属放线菌中发现的。 相似文献
6.
本文采用平板分离法从沉香样品中分离得到一株真菌 HNWSW-20,从形态学和分子生物学上鉴定其为曲霉菌(Aspergillus sp.),并利用多种色谱技术对其次生代谢产物进行分离纯化,根据波谱数据和理化性质鉴定其化合物结构为:2?,3?-dihydrosorbicillin(1),sorbicillin(2),2,3-二氢-2-(1-丙烯)-6,8-二甲基-7-羟基-色酮(3),邻苯二甲酸二丁酯(4),7-羟基-异苯并呋喃-1(3H)-酮(5)二十烷酸甲酯(6);分别采用 Ellman 比色法和 pNPG 法测定化合物的乙酰胆碱酯酶抑制活性和 α-葡萄糖苷酶抑制活性,结果显示上述化合物 1、2、4 具有乙酰胆碱酯酶抑制活性,而化合物 1、3、5 具有 α-葡萄糖苷酶抑制活性。本文中化合物 1~2 为首次从曲霉属中分离得到,并首次报道具有乙酰胆碱酯酶和 α-葡萄糖苷酶抑制活性。 相似文献
7.
海洋青霉HN89菌株次生代谢产物的抗菌活性与发酵条件对抗生素产量影响的研究结果表明:海洋青霉HN89菌株的次生代谢产物对细菌、酵母、霉菌均有抑制作用;摇瓶发酵产生抗生素(HN89A)的最佳培养基成分为:玉米淀粉20g/L,黄豆粉2g/L,K2HPO41g/L,NaCl0.5g/L,MgSO4 0.5g/L,FeSO4·7H2O0.01g/L,蛋白胨1g/L,用海水配制的海带汁(W/V,2%)1L,最佳发酵条件为28℃下振荡培养(200r/min)96~108h。合适的温度刺激能促进HN89A的合成。 相似文献
8.
9.
研究了分离自海洋虾壳的一株放线菌F-1013对几丁质的利用及其发酵液的优化。结果表明:该菌具有较高的几丁酶活力。通过对该菌发酵液的筛选和优化,认为该菌在pH8-9、5%的虾壳粉培养液中发酵5-7d,甲壳低聚糖含量达到0.3mg.mL-1,产菌量优于其他基质的培养基。 相似文献
10.
放线菌Snea49的种类鉴定及对胞囊线虫的活性评价 总被引:1,自引:0,他引:1
采用稀释分离法从辽宁沈阳市土壤中分离到1株放线菌Snea49.对Snea49进行了形态学特征、培养特征、生理生化特征及16S rDNA分析,初步鉴定为环状链霉菌(Streptomyces anulatus).利用离体测试法,研究了Snea49菌株代谢物不同倍数稀释液对大豆胞囊线虫的抑制作用.结果表明:10倍稀释液浓度下,该菌株对胞囊孵化的相对抑制率达82.60%,与无菌水对照差异显著.处理24h后,在1倍稀释液浓度下, 该菌株对2龄幼虫的校正死亡率是89.66%,各稀释浓度均与无菌水对照差异显著,该菌株有较高的杀线活性. 相似文献
11.
Se-eun Lee Min-ju Kim Prima F. Hillman Dong-Chan Oh William Fenical Sang-Jip Nam Kyung-Min Lim 《Marine drugs》2022,20(2)
The tricyclic quinazoline alkaloid deoxyvasicinone (DOV, 1) was isolated from a marine-derived Streptomyces sp. CNQ-617, and its anti-melanogenic effects were investigated. Deoxyvasicinone was shown to decrease the melanin content of B16F10 and MNT-1 cells that have been stimulated by α-melanocyte-stimulating hormone (α-MSH). In addition, microscopic images of the cells showed that deoxyvasicinone attenuated melanocyte activation. Although, deoxyvasicinone did not directly inhibit tyrosinase (TYR) enzymatic activity, real-time PCR showed that it inhibited the mRNA expression of TYR, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2). In the artificial 3D pigmented skin model MelanodermTM, deoxyvasicinone brightened the skin significantly, as confirmed by histological examination. In conclusion, this study demonstrated that the marine microbial natural product deoxyvascinone has an anti-melanogenic effect through downregulation of melanogenic enzymes. 相似文献
12.
Zhikai Guo Shiying Ma Salman Khan Hongjie Zhu Bo Zhang Shiqing Zhang Ruihua Jiao 《Marine drugs》2021,19(11)
Marine actinomycetes are prolific chemical sources of complex and novel natural products, providing an excellent chance for new drug discovery. The chemical investigation of the marine-derived Streptomyces sp. ITBB-ZKa6, from Zhaoshu island, Hainan, led to the discovery of two unique antimycin-type depsipeptides, zhaoshumycins A (1) and B (2), along with the isolation of the four known neoantimycins A (3), F (4), D (5), and E (6). The structures of the new compounds 1 and 2 were elucidated on the basis of the analysis of diverse spectroscopic data and biogenetic consideration. Zhaoshumycins A (1) and B (2) represent a new class of depsipeptides, featuring two neoantimycin monomers (only neoantimycin D or neoantimycins D and E) linked to a 1,4-disubstituted benzene ring via an imino group. Initial toxicity tests of 1–6 in MCF7 human breast cancer cells revealed that compounds 5 and 6 possess weak cytotoxic activity. Further structure–activity relationship analysis suggested the importance of the NH2 group at C-34 in 5 and 6 for cytotoxicity in MCF7 cells. 相似文献
13.
An extract prepared from the culture of a marine-derived actinomycete Streptomyces sp. ZZ338 was found to have significant antimicrobial and antiproliferative activities. A chemical investigation of this active extract resulted in the isolation of three known bioactive actinomycins (1–3) and two new metabolites (4 and 5). The structures of the isolated compounds were identified as actinomycins D (1), V (2), X0β (3), 2-acetylamino-3-hydroxyl-4-methyl-benzoic acid methyl ester (4), and N-1S-(4-methylaminophenylmethyl)-2-oxo-propyl acetamide (5) based on their nuclear magnetic resonance (NMR) and high resolution electrospray ionization mass spectroscopy (HRESIMS) data as well as their optical rotation. This class of new compound 5 had never before been found from a natural resource. Three known actinomycins showed activities in inhibiting the proliferation of glioma cells and the growth of methicillin-resistant Staphylococcus aureus, Escherichia coli, and Candida albicans and are responsible for the activity of the crude extract. Actinomycin D (1) was also found to downregulate several glioma metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis, suggesting that targeting multiple tumor metabolic regulators might be a new anti-glioma mechanism of actinomycin D. This is the first report of such a possible mechanism for the class of actinomycins. 相似文献
14.
Xu Hu Yuqi Tang Yuanyuan Liu Xinwei Pei Ziwei Huang Fuhang Song Huawei Zhang 《Marine drugs》2022,20(5)
Chrysomycin A is one of the most promising therapeutic candidates for treating infections caused by multidrug-resistant Gram-positive bacteria. By hybridizing next-step generation (Illumina) and third-generation (PacBio) sequencing technologies, a high-quality chromosome-level genome together with a plasmid was firstly assembled for chrysomycin A-producing marine strain 891. Phylogenetic analysis of the 16S rRNA gene and genome sequences revealed that this strain unambiguously belonged to the genus Streptomyces, and its genomic features and functional genes were comprehensively analyzed and annotated. AntiSMASH analysis of this strain unveiled one key biosynthetic gene cluster, T2PKS, responsible for the biosynthesis of chrysomycin, the biosynthesis pathway of which was putatively proposed. These findings definitely shed light on further investigation for construction of a robust industrial strain with high-yield chrysomycin A production using genetic engineering techniques and combinatorial biology approaches. 相似文献
15.
Wei Liu Liang Ma Liping Zhang Yuchan Chen Qingbo Zhang Haibo Zhang Weimin Zhang Changsheng Zhang Wenjun Zhang 《Marine drugs》2022,20(7)
Two new phenylhydrazone derivatives and one new alkaloid, penzonemycins A–B (1–2) and demethylmycemycin A (3), together with three known compounds including an alkaloid (4) and two sesquiterpenoids (5–6), were isolated from the Streptomyces sp. SCSIO 40020 obtained from the Pearl River Estuary sediment. Their structures and absolute configurations were assigned by 1D/2D NMR, mass spectroscopy and X-ray crystallography. Compound 1 was evaluated in four human cancer cell lines by the SRB method and displayed weak cytotoxicity in three cancer cell lines, with IC50 values that ranged from 30.44 to 61.92 µM, which were comparable to those of the positive control cisplatin. Bioinformatic analysis of the putative biosynthetic gene cluster indicated a Japp–Klingemann coupling reaction involved in the hydrazone formation of 1 and 2. 相似文献
16.
为从昆虫来源的放线菌次级代谢产物中寻找药物先导分子,对铜绿金龟子幼虫肠道链霉菌Streptomyces sp. BCa1菌丝体化学成分进行了研究。通过活性跟踪,从其菌丝体的氯仿甲醇萃取物中分离得到主要成分1。利用高分辨质谱、一维和二维核磁波谱技术,将该主要成分1鉴定为具有双重旋转对称结构的不饱和大环内酯类抗生素阿扎霉素(elaiophylin),具有显著的抗金黄色葡萄球菌活性。该类化合物为首次从昆虫来源的放线菌中发现。 相似文献
17.
18.
Streptomyces sp. SCSIO ZS0520 is a deep-sea hydrothermal vent-derived actinomycete. Our previous metabolism investigation showed that Streptomyces sp. SCSIO ZS0520 is a producer of cytotoxic actinopyrones. Here, another four types of secondary metabolites were identified, including six salinomycin isomers (2–7), the macrolide elaiophylin (8), the triterpene N-acetyl-aminobacteriohopanetriol (9), and the pyrone minipyrone (10). Among them, compounds 2–6 and 10 are new compounds. To understand the biosynthetic pathway of these compounds, a bioinformatic analysis of the whole genome was carried out, which identified 34 secondary metabolite biosynthetic gene clusters. Next, the biosynthetic pathways responsive to four types of products were deduced on the basis of gene function predictions and structure information. Taken together, these findings prove the metabolite potential of ZS0520 and lay the foundations to solve the remaining biosynthetic issues in four types of marine natural products. 相似文献
19.
Jinsheng Cui Eunji Kim Dong Hyun Moon Tae Ho Kim Ilnam Kang Yeonjung Lim Daniel Shin Sunghoon Hwang Young Eun Du Myoung Chong Song Munhyung Bae Jang-Cheon Cho Jichan Jang Sang Kook Lee Yeo Joon Yoon Dong-Chan Oh 《Marine drugs》2022,20(6)
Two new lipo-decapeptides, namely taeanamides A and B (1 and 2), were discovered from the Gram-positive bacterium Streptomyces sp. AMD43, which was isolated from a mudflat sample from Anmyeondo, Korea. The exact molecular masses of 1 and 2 were revealed by high-resolution mass spectrometry, and the planar structures of 1 and 2 were elucidated using NMR spectroscopy. The absolute configurations of 1 and 2 were determined using a combined analysis of 1H-1H coupling constants and ROESY correlations, the advanced Marfey’s method, and bioinformatics. The putative nonribosomal peptide synthetase pathway for the taeanamides was identified by analyzing the full genome sequence data of Streptomyces sp. AMD43. We also found that taeanamide A exhibited mild anti-tuberculosis bioactivity, whereas taeanamide B showed significant bioactivity against several cancer cell lines. 相似文献
20.
A new cyclic diamine, 1,5-diazacyclohenicosane (1), was isolated from samples of the marine sponge Mycale sp. collected at Lamu Island (Kenya). Its structure was determined by a combination of spectroscopic techniques, including (+)-HRESIMS and 1D and 2D NMR spectroscopy. The compound displayed cytotoxicity at the μM level against three human tumor cell lines. 相似文献